Advanced Search Results

1704 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
BRCA1 and CDK1 breast cancer 1, early onset cyclin-dependent kinase 1
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Phosphorylation of the APC/C
  • Signaling by FGFR in disease
  • Phosphorylation of Emi1
  • Signaling by EGFRvIII in Cancer
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Mitotic G1-G1/S phases
  • SHC-mediated signalling
  • Recruitment of mitotic centrosome proteins and complexes
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • Nuclear Pore Complex (NPC) Disassembly
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • ERK1 activation
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Signaling by VEGF
  • Resolution of Sister Chromatid Cohesion
  • Downstream signal transduction
  • Signalling to RAS
  • Toll Like Receptor 3 (TLR3) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-2 signaling
  • Mitotic G2-G2/M phases
  • Frs2-mediated activation
  • MASTL Facilitates Mitotic Progression
  • Axon guidance
  • IRS-mediated signalling
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • Cyclin A/B1 associated events during G2/M transition
  • Loss of Nlp from mitotic centrosomes
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Condensation of Prometaphase Chromosomes
  • Signaling by Insulin receptor
  • E2F mediated regulation of DNA replication
  • Insulin receptor signalling cascade
  • Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
  • G0 and Early G1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • Signaling by FGFR
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • E2F-enabled inhibition of pre-replication complex formation
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • Signaling by GPCR
  • G2/M Checkpoints
  • Mitotic Prophase
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • FCERI mediated MAPK activation
  • Regulation of PLK1 Activity at G2/M Transition
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • G1/S Transition
  • G1/S-Specific Transcription
  • Toll Like Receptor 9 (TLR9) Cascade
  • G2/M DNA replication checkpoint
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Condensation of Prophase Chromosomes
  • Signaling by Leptin
  • Signalling to ERKs
  • Mitotic Prometaphase
  • Prolonged ERK activation events
  • Organelle biogenesis and maintenance
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Envelope Breakdown
  • IGF1R signaling cascade
  • Recruitment of NuMA to mitotic centrosomes
  • Cyclin B2 mediated events
  • Toll Like Receptor TLR6:TLR2 Cascade
  • M Phase
  • IRS-related events triggered by IGF1R
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • Downstream signaling of activated FGFR
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Signalling by NGF
  • SOS-mediated signalling
  • G2/M DNA damage checkpoint
  • MAP kinase activation in TLR cascade
  • SHC-mediated signalling
  • Depolymerisation of the Nuclear Lamina
  • Assembly of the primary cilium
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • SHC1 events in EGFR signaling
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Centrosome maturation
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
BRCA1 and HGF breast cancer 1, early onset hepatocyte growth factor (hepapoietin A; scatter factor)
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Signaling by Interleukins
  • Response to elevated platelet cytosolic Ca2+
  • Interleukin-7 signaling
  • Cytokine Signaling in Immune system
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
BRCA1 and UBE2K breast cancer 1, early onset ubiquitin-conjugating enzyme E2K
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Negative regulators of RIG-I/MDA5 signaling
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Adaptive Immune System
BRCA1 and LCK breast cancer 1, early onset LCK proto-oncogene, Src family tyrosine kinase
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Regulation of KIT signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • CD28 co-stimulation
  • Host Interactions of HIV factors
  • CD28 dependent PI3K/Akt signaling
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • TCR signaling
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • HIV Infection
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Nef Mediated CD4 Down-regulation
  • Innate Immune System
  • Signalling by NGF
  • Generation of second messenger molecules
  • Translocation of ZAP-70 to Immunological synapse
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • CTLA4 inhibitory signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • CD28 dependent Vav1 pathway
  • PECAM1 interactions
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • PD-1 signaling
  • GPVI-mediated activation cascade
  • Phosphorylation of CD3 and TCR zeta chains
  • Dasatinib
  • {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid
  • Staurosporine
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE
  • 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
  • N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
  • Ponatinib
BRCA1 and UBB breast cancer 1, early onset ubiquitin B
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Signaling by FGFR in disease
  • Hedgehog 'off' state
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Glucose metabolism
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • HIV Infection
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • Activated TLR4 signalling
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • Membrane binding and targetting of GAG proteins
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Regulation of the Fanconi anemia pathway
  • Generic Transcription Pathway
  • G1/S Transition
  • Toll Like Receptor 9 (TLR9) Cascade
  • FBXW7 Mutants and NOTCH1 in Cancer
  • IRAK1 recruits IKK complex
  • Negative regulation of FGFR signaling
  • truncations of AMER1 destabilize the destruction complex
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • TRAF6 mediated induction of TAK1 complex
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • T41 mutants of beta-catenin aren't phosphorylated
  • Cellular Senescence
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Assembly Of The HIV Virion
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • NOD1/2 Signaling Pathway
  • Glycogen storage diseases
  • MyD88 dependent cascade initiated on endosome
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • Interleukin-1 signaling
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • TGFBR1 LBD Mutants in Cancer
  • Oncogene Induced Senescence
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Disease
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Toll-Like Receptors Cascades
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by EGFR in Cancer
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
BRCA1 and UBE2D1 breast cancer 1, early onset ubiquitin-conjugating enzyme E2D 1
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Loss of Function of TGFBR2 in Cancer
  • Phosphorylation of the APC/C
  • Negative regulators of RIG-I/MDA5 signaling
  • Cellular Senescence
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • APC/C:Cdc20 mediated degradation of Securin
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Signaling by BMP
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TRIF-mediated TLR3/TLR4 signaling
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Loss of Function of SMAD4 in Cancer
  • Senescence-Associated Secretory Phenotype (SASP)
  • TGFBR1 KD Mutants in Cancer
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C-mediated degradation of cell cycle proteins
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Cellular response to hypoxia
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Separation of Sister Chromatids
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • M Phase
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Mitotic Spindle Checkpoint
  • Activated TLR4 signalling
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Loss of Function of SMAD2/3 in Cancer
  • IKK complex recruitment mediated by RIP1
  • TGFBR2 Kinase Domain Mutants in Cancer
  • MyD88-independent cascade
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll-Like Receptors Cascades
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • SMAD4 MH2 Domain Mutants in Cancer
BRCA1 and UBE2D2 breast cancer 1, early onset ubiquitin-conjugating enzyme E2D 2
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Cellular response to hypoxia
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Negative regulators of RIG-I/MDA5 signaling
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • IKK complex recruitment mediated by RIP1
  • TRIF-mediated TLR3/TLR4 signaling
  • MyD88-independent cascade
  • Activated TLR4 signalling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Adaptive Immune System
BRCA1 and UBE2E1 breast cancer 1, early onset ubiquitin-conjugating enzyme E2E 1
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Phosphorylation of the APC/C
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Separation of Sister Chromatids
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Cellular Senescence
  • Mitotic Anaphase
  • APC/C:Cdc20 mediated degradation of Securin
  • M Phase
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Mitotic Spindle Checkpoint
  • Class I MHC mediated antigen processing & presentation
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Cytokine Signaling in Immune system
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Senescence-Associated Secretory Phenotype (SASP)
  • Regulation of APC/C activators between G1/S and early anaphase
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Cell Cycle, Mitotic
  • APC/C-mediated degradation of cell cycle proteins
  • Antiviral mechanism by IFN-stimulated genes
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Regulation of mitotic cell cycle
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • Cell Cycle Checkpoints
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
BRCA1 and UBE2E2 breast cancer 1, early onset ubiquitin-conjugating enzyme E2E 2
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
BRCA1 and UBE2L3 breast cancer 1, early onset ubiquitin-conjugating enzyme E2L 3
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
BRCA1 and UBE2N breast cancer 1, early onset ubiquitin-conjugating enzyme E2N
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • IRAK1 recruits IKK complex
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Class I MHC mediated antigen processing & presentation
  • IRAK1 recruits IKK complex
  • Innate Immune System
  • ISG15 antiviral mechanism
  • TRIF-mediated TLR3/TLR4 signaling
  • IKK complex recruitment mediated by RIP1
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Antiviral mechanism by IFN-stimulated genes
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-1 signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Adaptive Immune System
BRCA1 and UBE3A breast cancer 1, early onset ubiquitin protein ligase E3A
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
BRCA1 and SUMO1 breast cancer 1, early onset small ubiquitin-like modifier 1
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Interferon gamma signaling
  • SUMO is proteolytically processed
  • Post-translational protein modification
  • SUMOylation
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • SUMO is conjugated to E1 (UBA2:SAE1)
  • Regulation of IFNG signaling
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • Processing and activation of SUMO
BRCA1 and PIK3R1 breast cancer 1, early onset phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
BRCA1 and POLR2H breast cancer 1, early onset polymerase (RNA) II (DNA directed) polypeptide H
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Regulatory RNA pathways
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • Influenza Life Cycle
  • RNA Polymerase III Transcription Termination
  • HIV elongation arrest and recovery
  • NoRC negatively regulates rRNA expression
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase III Chain Elongation
  • RNA Polymerase III Transcription
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Abortive And Retractive Initiation
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • PIWI-interacting RNA (piRNA) biogenesis
  • mRNA Splicing
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Clearance
  • HIV Infection
  • Formation of the Early Elongation Complex
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Transcriptional regulation of pluripotent stem cells
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Innate Immune System
  • RNA Polymerase III Transcription Initiation
  • Transcriptional regulation by small RNAs
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • RNA Polymerase I Transcription
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • Cytosolic sensors of pathogen-associated DNA
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Pausing and recovery of HIV elongation
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
BRCA1 and PSMA6 breast cancer 1, early onset proteasome (prosome, macropain) subunit, alpha type, 6
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • T41 mutants of beta-catenin aren't phosphorylated
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • Stabilization of p53
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • DNA Replication Pre-Initiation
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Autodegradation of the E3 ubiquitin ligase COP1
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Adaptive Immune System
  • CDK-mediated phosphorylation and removal of Cdc6
  • Hedgehog ligand biogenesis
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Separation of Sister Chromatids
  • HIV Infection
  • Ubiquitin-dependent degradation of Cyclin D
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • p53-Dependent G1 DNA Damage Response
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • p53-Independent DNA Damage Response
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Vpu mediated degradation of CD4
  • Synthesis of DNA
  • M/G1 Transition
  • Ubiquitin-dependent degradation of Cyclin D1
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Signaling by Hedgehog
  • Regulation of mitotic cell cycle
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • p53-Dependent G1/S DNA damage checkpoint
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • CDK-mediated phosphorylation and removal of Cdc6
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • truncations of AMER1 destabilize the destruction complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic Metaphase and Anaphase
  • Regulation of ornithine decarboxylase (ODC)
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Metabolism of amino acids and derivatives
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • Regulation of DNA replication
  • Cell Cycle, Mitotic
  • beta-catenin independent WNT signaling
  • Orc1 removal from chromatin
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Antigen processing-Cross presentation
  • CDT1 association with the CDC6:ORC:origin complex
  • ER-Phagosome pathway
BRCA1 and XRCC5 breast cancer 1, early onset X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Cytosolic sensors of pathogen-associated DNA
  • HIV Infection
  • Processing of DNA ends prior to end rejoining
  • Integration of provirus
  • Early Phase of HIV Life Cycle
  • HIV Life Cycle
  • Nonhomologous End-joining (NHEJ)
  • STING mediated induction of host immune responses
  • Double-Strand Break Repair
  • IRF3-mediated induction of type I IFN
  • 2-LTR circle formation
  • Innate Immune System
BRCA1 and IFI16 breast cancer 1, early onset interferon, gamma-inducible protein 16
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Cytosolic sensors of pathogen-associated DNA
  • STING mediated induction of host immune responses
  • IRF3-mediated induction of type I IFN
  • Innate Immune System
BRCA1 and CREBBP breast cancer 1, early onset CREB binding protein
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Metabolism of lipids and lipoproteins
  • Signaling by Wnt
  • Regulation of gene expression by Hypoxia-inducible Factor
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • Pre-NOTCH Transcription and Translation
  • RNF mutants show enhanced WNT signaling and proliferation
  • Signaling by NOTCH1 in Cancer
  • Orphan transporters
  • Chromatin organization
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • Factors involved in megakaryocyte development and platelet production
  • Chromatin modifying enzymes
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional activation of mitochondrial biogenesis
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • PPARA activates gene expression
  • Cellular response to hypoxia
  • Organelle biogenesis and maintenance
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Attenuation phase
  • HATs acetylate histones
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • HSF1-dependent transactivation
  • TRAF3-dependent IRF activation pathway
  • Signaling by NOTCH1
  • Transcriptional regulation of white adipocyte differentiation
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Pre-NOTCH Expression and Processing
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Innate Immune System
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Cytosolic sensors of pathogen-associated DNA
  • Cellular response to heat stress
  • REV-ERBA represses gene expression
  • Mitochondrial biogenesis
  • Notch-HLH transcription pathway
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • NOTCH1 Intracellular Domain Regulates Transcription
  • TCF dependent signaling in response to WNT
  • TRAF6 mediated IRF7 activation
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Signaling by WNT in cancer
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
BRCA1 and PPP2R5C breast cancer 1, early onset protein phosphatase 2, regulatory subunit B, gamma
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • Fanconi Anemia pathway
  • ATM mediated response to DNA double-strand break
  • Homologous Recombination Repair
  • Meiotic synapsis
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • Mitotic Prometaphase
  • Costimulation by the CD28 family
  • Separation of Sister Chromatids
  • misspliced GSK3beta mutants stabilize beta-catenin
  • APC truncation mutants have impaired AXIN binding
  • T41 mutants of beta-catenin aren't phosphorylated
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Mitotic Anaphase
  • Signaling by Wnt
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Degradation of beta-catenin by the destruction complex
  • S37 mutants of beta-catenin aren't phosphorylated
  • RNF mutants show enhanced WNT signaling and proliferation
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Beta-catenin phosphorylation cascade
  • truncations of AMER1 destabilize the destruction complex
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • CTLA4 inhibitory signaling
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • Cell Cycle, Mitotic
  • Platelet homeostasis
  • deletions in the AMER1 gene destabilize the destruction complex
  • TCF dependent signaling in response to WNT
  • Platelet sensitization by LDL
  • AMER1 mutants destabilize the destruction complex
  • Resolution of Sister Chromatid Cohesion
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by WNT in cancer
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
Page 8 out of 86 pages